Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Buprenorphine Combination Tablet Feasibility - 1 Clinical Trials References presented on Clinical Trials Search isn't meant to be a substitute for proven healthcare advice, trips or professional assistance using a genuine physician. We are not docs. Always confer with your physician about Buprenorphine Combination Tablet Feasibility - 1 conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Buprenorphine Combination Tablet Feasibility - 1 Clinical research trials and Buprenorphine Combination Tablet Feasibility - 1 healthcare trials happen in hundreds of localities throughout the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the potency of new drugs. The propose of the studies / projects is to answer particular human health questions. Clinical trials are a popular way for mDs, government agencies, and private sector companies to detect cures for all sorts of conditions, such as Buprenorphine Combination Tablet Feasibility - 1. Buprenorphine Combination Tablet Feasibility - 1 Clinical Trials and other clinical trials allow volunteers to acquire healthcare treatment choices before they are available to the general public. Some times the subjects recieve professional assistance for free, and every now and again they are compensated for their time. Sometimes there is a cost for a Buprenorphine Combination Tablet Feasibility - 1 clinical trial. Subjects frequently obtain the most expert healthcare possible for their Buprenorphine Combination Tablet Feasibility - 1 condition. Risks are a reality, nevertheless, and can include more or frequent doctor trips, medical risks (possibly life-threatening), and/or the treatment being uneffective. Trials are federally governed with stern guidelines to protect clinical trials patients.

Home > "B" Clinical Trials Conditions > Buprenorphine Combination Tablet Feasibility - 1

Buprenorphine Combination Tablet Feasibility - 1



Buprenorphine Combination Tablet Feasibility - 1

For Condition: Opioid-Related Disorders
Status: Completed
Sponsor(s): National Institute on Drug Abuse (NIDA) ,
Synopsis: 1) Determine target dose range of buprenorphine/naloxone combination tablet that provides therapeutic response in opiate addicts with low to moderate dependence. 2) Identify appropriate initial induction dose in opiate addicts with low to moderate dependence.
Details:
Eligibility:
Study Type:
  Interventional, Treatment, Double-Blind, Placebo Control
Minimum Age/Maximum Age: 21 Years/50 Years
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: Males/Females ages 21-50, opiate dependence according to DSM-IV criteria, self-reported use within the last 30 days, agreeable to conditions of study and signed informed consent Exclusion Criteria: Psychiatric disorder that requires medication therapy, history of seizures, pregnant and/or nursing women, dependence on etoh or benzodiazepines or other sedative-hypnotics, acute hepatitis, other medical conditions that deem participation to be unsafe.
Total Enrollment: 0

Location and Contact Information:

Overall Study Official:
WalterLing,  Principal Investigator,  Friends Research Institute

Friends Research Institute
Los Angeles,  California,  90025
United States
 


Additional Information:
Study ID Numbers:
  NIDA-09260-1;  P50-09260-1
Study Start Date: August 1995
Record last reviewed: January 1996
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00000298

Other Opioid-Related Disorders Studies:
1. Efficacy/Safety Trial of Buprenorphine/Nx for Opiate Dependence - 2

2. CS1008A Efficacy/Safety Trial of Buprenorphine/Naloxone - 1

3. Alternate Day Buprenorphine Administration, Phase XII - 17

4. Cold Water Immersion Modulates Reinforcing Effects of Nitrous Oxide - 2

5. Alternate Day Buprenorphine Administration, Phase IX - 14

Related Studies:

Other Opioid-Related Disorders Clinical Trials
Other California Clinical Trials
Other Los Angeles Clinical Trials

Buprenorphine Combination Tablet Feasibility - 1

Modify your Search

  Other Opioid-Related Disorders Clinical Trials
  Other California Clinical Trials
  Other Los Angeles Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103